Cargando…
Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans
BACKGROUND: There is a strong need for biomarkers to better characterize individuals with COPD and to take into account the heterogeneity of COPD. The blood protein sRAGE has been put forward as promising biomarker for COPD in general and emphysema in particular. Here, we measured plasma sRAGE level...
Autores principales: | Klont, Frank, Horvatovich, Peter, Bowler, Russell P., van Rikxoort, Eva, Charbonnier, Jean-Paul, Kwiatkowski, Marcel, Lynch, David A., Humphries, Stephen, Bischoff, Rainer, ten Hacken, Nick H. T., Pouwels, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785488/ https://www.ncbi.nlm.nih.gov/pubmed/35073932 http://dx.doi.org/10.1186/s12931-022-01934-w |
Ejemplares similares
-
Reply to Biswas: Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Pouwels, Simon D., et al.
Publicado: (2019) -
Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Pouwels, Simon D., et al.
Publicado: (2019) -
Affimers as an
Alternative to Antibodies in an Affinity
LC–MS Assay for Quantification of the Soluble Receptor of Advanced
Glycation End-Products (sRAGE) in Human Serum
por: Klont, Frank, et al.
Publicado: (2018) -
The Decrease in Serum sRAGE Levels Upon Smoking is Associated with Activated Neutrophils
por: Wiersma, Valerie R., et al.
Publicado: (2022) -
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)